# Top 45 Medical Angel Investors in Canada in May 2026

## Jevon MacDonald
- Type: Angel
- Location: Halifax, Nova Scotia, Canada
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Predictive Analytics, Enterprise Software

Jevon MacDonald is the Co-Founder at StartupNorth.

## James Lochrie
- Type: Angel
- Location: Calgary, Alberta, Canada
- Relevant deals: 2
- Stages: Seed, Angel, Pre-Seed
- Focus: Software, Medical, Health Care

James Lochrie is an entrepreneur, angel investor, venture capitalist and volunteer. He is the Co-founder of the global fintech company Wave. He is a Partner at Thin Air Labs, overseeing Thin Air Fund 1 and the Capital team. He has worked with thousands of entrepreneurs to help them scale their companies and #BuildWhatsNext.

## Jonathan Keidan
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: E-Commerce, Food and Beverage, Health Care

Jonathan is the Founder of Torch Capital. A long time entrepreneur and investor, he has spent his career at the intersection of the media, technology and entertainment industries. He is the Co-Founder of digital media company InsideHook and has spent a decade as an active early stage investor and advisor to a number of New York and LA's topstart-ups.

## Kai Kux
- Type: Angel
- Location: Kuala Lumpur, Kuala Lumpur, Malaysia
- Relevant deals: 1
- Stages: Angel
- Focus: Medical, Health Care, Personal Health

Managing Director & Venture Partner at
Asia Venture Group

## Tobyn Sowden
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: iOS, Music, Android

Tobyn Sowden is the CEO at Redbrick.He attended University of Victoria.

## Andrew Wilkinson
- Type: Angel
- Location: Victoria, British Columbia, Canada
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Internet, SaaS

Andrew Wilkinson is the founder of Flow. Andrew Wilkinson attended Ryerson University in 2004.

## Frederic Ors
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Health Care, Biotechnology

Fred has served as our Chief Executive Officer since April 2016. As CEO, he has led the transformation of IMV into a leading clinical-stage immune-oncology company with world-class collaborators and a strong scientific foundation. He has more than 21 years of experience in the biopharmaceutical industry, having served in several managementpositions encompassing business development, intellectual property, strategic planning, pre-marketing, and communication. Before joining IMV, Fred spent 14 years at Medicago serving in many roles of increasing responsibility, most recently as Vice President of Business Development and Strategic Planning. He had been an integral part of Medicago’s success, including securing more than $300M CAN in non-dilutive funding in revenues and future milestones from licensing agreements and government contracts, and the $357M CAN deal acquisition by Mitsubishi Pharma in 2013.Fred is also a Director of CQDM, a biopharmaceutical research consortium and served as second Vice-Chair of the Vaccine Industry Committee of Biotech Canada between 2012 and 2016. Prior to Medicago, Fred was Licensing Manager at the University Paris VII-Denis Diderot, one of the largest sciences and medical university in France. He owns a BSc degree in Biology and a Master’s degree in Biotechnology and Business Management from the University of Angers (France).

## Louis Charbonneau
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Software, Health Care

Louis Charbonneau is a co-founder of DXA.

## Milad Alucozai
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Biotechnology, Health Care, Medical

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

## Paul Buchheit
- Type: Angel
- Location: Mountain View, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Angel
- Focus: Software, Health Care, E-Commerce

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

## Robert Simon
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Software, Task Management, B2B

Robert Simon is the Sr. Managing Partner, IT Venture Fund at BDC.

## Daniel Debow
- Type: Angel
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Enterprise Software

Daniel is the Vice President of Product (Demand) at Shopify. He previously worked as an SVP at Salesforce.com, where he drives marketing for Salesforce Work.com, a sales performance management solution that helps Facebook, LinkedIn, Spotify, and other innovative companies align, motivate, and drive the performance of their sales teams. Prior tojoining Salesforce, Daniel was co-founder and co-CEO of Rypple, a social performance management platform acquired by Salesforce in 2012. Prior to Rypple, Daniel was on the founding team of Workbrain, which provided workforce management solutions to Wal-Mart, Citibank, and other large enterprises. Workbrain grew to $100 million in annual revenues before being acquired by Infor in 2007.A sought after speaker on how social media is changing the workplace, Daniel is a contributor to Fortune.com and the Huffington Post. He’s been widely quoted in Wired, the Financial Times, the Economist and Bloomberg Businessweek. Daniel holds a JD/MBA from the University of Toronto and an LLM in Law, Science and Technology from Stanford University.

## bumpkins profile
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Health Care, Biotechnology, Software

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

## Alexandre Tratch
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Software, Health Care

Alexandre Tratch is a co-founder of DXA.

## Tony Fadell
- Type: Angel
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Information Technology, Artificial Intelligence, Hardware

Tony Fadell led the team that created the first 18 generations of the iPod and the first three generations of the iPhone. Before Apple, Tony built the Mobile Computing Group at Philips Electronics. Tony has authored more than 100 patents. He graduated from the University of Michigan with a Bachelors in Computer Engineering.

## Alexandre Grenier
- Type: Angel
- Relevant deals: 1
- Focus: Health Care

Alexandre Grenier is a businessman and specialist in the marketing of pharmaceuticals

## Cherif Habib
- Type: Angel
- Location: Montréal, Quebec, Canada
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Information Technology, Health Care, Software

Cherif Habib is a co-Founder and the CEO at Dialogue. He is also a mentor at Creative Destruction Lab.

## Rob Fraser
- Type: Angel
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: Advertising, Health Care, Sales and Marketing

Rob Fraser currently works as the Founder and CEO for Endur Apparel.

## Rande Gerber
- Type: Angel
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Health Care, Fitness, Wellness

Rande Gerber is the founder and chairman of Casamigos Tequila. In 2013, Rande partnered with longtime friends George Clooney and Mike Meldman to launch Casamigos. Under Mr. Gerber’s leadership, Casamigos quickly became the fastest growing ultra-premium tequila in the country. Four years later, in 2017, Casamigos was acquired by Diageo for $1billion. Casamigos has garnered the highest accolades from the spirit industry’s most well-respected authority figures. Rande continues to steer the company with record breaking growth.Early in his career, Rande created the influential nightlife entities Midnight Oil Company and Gerber Group, establishing himself as a preeminent hospitality entrepreneur with an uncanny ability to know his consumer. He created cool and classic properties with an international and high profile clientele. He first made his mark in 1989 by opening The Whiskey Bar at Ian Schrager’s Paramount Hotel in NYC. Rande elevated the concept of the “hotel bar” by creating The Whiskey Bar’s upscale lounges, including The Whiskey, Whiskey Blue, Whiskey Park, The Penthouse, Midnight Rose, Stone Rose and SkyBar Los Angeles. Rande opened The Whiskey on Ocean Drive in South Beach in 1991 and is credited with being the original pioneer of South Beach nightlife. Rande went on to open 40 lounges, bars, restaurants and clubs in major cities including New York, Los Angeles, Miami, Las Vegas, Boston, Chicago, Madrid and Mexico
City. His extraordinary success made his companies the preferred partner for Starwood Hotels, W Hotels, Sofitel, Strategic Hotel Group and Sol Melia.Rande has been featured on television and in magazines and newspapers including The New York Times, Wall Street journal, Bloomberg, Business Insider, GQ, Architectural Digest, Vanity Fair, MSNBC, and CNN among others.Rande’s philanthropic involvement includes the Juvenile Diabetes Foundation, Boys & Girls Clubs, American Children’s Hospital and more.He currently resides with his wife, Cindy Crawford, and two children, Kaia and Presley Gerber, in Malibu, California.

## Ryan Pawell
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Biopharma, Biotechnology

Ryan Pawell (Founder, Director & Chief Executive Officer) is a Y Combinator alumni, published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and biomicrofluidics. Ryan has been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force,National Institutes of Health, and National Cancer Institute among others.

## Collin Terpstra
- Type: Angel
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Biotechnology

Collin Terpstra is an allergy specialist.

## Vishal Rao
- Type: Angel
- Location: Boston, Massachusetts, United States
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Artificial Intelligence, Information Technology

Advisory CTO and Angel Investor

## Justin Allport
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Software, Health Care

Justin Allport

## David Fraga
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Internet, Software, SaaS

David Fraga is President of InVision where helps the team fulfill its mission of unlocking the power of design-driven product development for companies of all sizes.Previously, David was VP of Corporate Development at Shutterstock (NYSE: SSTK), a global marketplace for imagery, providing the digital building blocks that creators need to expressthemselves visually. David helped Shutterstock grow from $50M to over $400M in annual revenue and through the company’s IPO. David also worked at Insight Venture Partners, a technology-focused private equity and venture capital firm, where he helped invest more than $170 million in software and Internet companies, including the firm's investment in Twitter.David graduated from the University of Pennsylvania with a bachelor of arts in economics and political science. He serves on the Board of Advisors of TechiesGiveBack and RaisedBy.us, which has raised hundreds of thousands of dollars and organized grassroots volunteer efforts for local charities by mobilizing the tech community to contribute to employee-identified causes.

## Scott Lake
- Type: Angel
- Location: Vancouver, British Columbia, Canada
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, FinTech, Communities

Scott Lake is a startup entrepreneur, tech investor, and philanthropist. He is best known as the cofounder of Shopify (NYSE: SHOP), then later as founder of Source Metrics.Currently, Scott is a general partner at Hello Ventures, where he leverages all the learning from his entrepreneurial journeys to invest in and advise early-stage techcompanies.Scott also plays an active role with his wife Jess as philanthropic funders of diverse social and public health causes.In his past lives, he has been a bike messenger, a university lecturer, a driver at NATO, and a political science PhD.

## Nasir Jones
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: E-Commerce, Internet, Software

Nas, byname of Nasir bin Olu Dara Jones, also called Nasty Nas, (born September 14, 1973, Brooklyn, New York, U.S.), American rapper and songwriter who became a dominant voice in 1990s East Coast hip-hop. Nas built a reputation as an expressive chronicler of inner-city street life.Nasir Jones, the son of a jazz musician, grew up in public housingin Queens, New York. He dropped out of school in the eighth grade and searched for a creative outlet, finally settling on hip-hop. His breakthrough came in 1992, when his song “Half Time” (credited to Nasty Nas) appeared on the sound track to the film Zebrahead. Columbia Records soon signed him to a contract. His debut recording as Nas, Illmatic (1994), drew widespread acclaim for its poetic narration of hard-edged inner-city life.The more pop-oriented approach of It Was Written (1996) helped that album reach an even wider audience than its predecessor but ignited a recurring tension in Nas’s career between the appetite of the pop audience and the demands of hip-hop purists. He maintained his commercial appeal with I Am... (1999), although by that time he had also become embroiled in a public feud with fellow rapper Jay-Z over which of the two was the preeminent voice in East Coast hip-hop. The schism inspired Stillmatic (2001), which many fans considered a return to form. The two rappers publicly settled their differences in 2005, and shortly thereafter Nas signed with Def Jam, of which Jay-Z was president at the time.Nas’s penchant for provocation marked Hip Hop Is Dead (2006) and an untitled follow-up (2008), while Life Is Good (2012) struck an introspective tone. He also notably collaborated with reggae musician Damian Marley (the youngest son of Bob Marley) on the album Distant Relatives (2010).Nas also made occasional film appearances, notably in Belly (1998), a crime drama in which he starred opposite rapper DMX, and Black Nativity (2013), an adaptation of Langston Hughes’s gospel play.

## Rasool Rayani
- Type: Angel
- Location: Victoria, British Columbia, Canada
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: SaaS, Content, Cloud Computing

Rasool is a serial entrepreneur with experience in the software, healthcare, and CPG industries. He continues to maintain his passion for technology as an active angel investor with a focus on b2b, consumer saas and health tech. Rasool maintains an active role with CEO’s as a board member, mentor and advisor. He currently serves on the boards ofthe Victoria Foundation, VIATEC, and Checkfront Software.

## Timothy A. Springer
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Medical, Health Care

Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.

## Cindy Crawford
- Type: Angel
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Health Care, Fitness, Wellness

Cynthia Ann "Cindy" Crawford is an American model and actress. Her years of success at modeling made her an international celebrity that has led to roles in television and film, and to work as a spokesperson.

## Anne Wojcicki
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Health Care, Medical, Biotechnology

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

## Kerry Liu
- Type: Angel
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: SaaS, Medical, Big Data

Kerry Liu is an Executive Vice President, Product Management & Innovation at Kinaxis.

## Niels Gron
- Type: Angel
- Relevant deals: 1
- Stages: Convertible Note, Seed, Pre-Seed
- Focus: Software, Artificial Intelligence, Information Technology

Niels Gron

## Amit Sharma
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: E-Commerce, Food and Beverage, Retail

Amit Sharma is the Founder & General Partner at Black Jays Investments where he is responsible for sourcing, evaluating, and ultimately investing in early stage consumer/tech start-ups.

## Nelson Chu
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Series A, Series C
- Focus: Health Care, FinTech, Financial Services

Nelson Chu is the founder and CEO of Percent, the leading digital securitization and investment platform for private debt. Their comprehensive software suite facilitates the structuring and issuance of debt capital at any size and scale. Prior to Percent, he founded a strategy consulting firm specializing in helping companies build products andraise capital for growth, creating over $1B in equity value. He began his career at several of the top financial services firms, including Bank of America and BlackRock.  He is an active angel investor, with notable fintech investments including BlockFi, Care/Of (Acq: Bayer AG), Clover Health (NAS: CLOV), dv01, Eden Health, Plentina, Tala, and Uala.

## Jacky Chen
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Health Care, Information Technology

Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania.

## Wei Guo
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Angel
- Focus: Software, Artificial Intelligence, Health Care

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

## Zen Chu
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Health Care, Medical, mHealth

Zen Chu believes that now is the best time in history for healthcare entrepreneurs and engineers to create the data, systems and products to help medicine scale and serve more patients with higher quality at lower cost. He created and teaches the MIT Healthcare Ventures graduate courses within the pioneering Health Science & Technology (HST)program, a joint initiative between MIT, Harvard Medical School and the Boston academic hospitals. As faculty director for the HackingMedicine.MIT.edu health innovation leadership initiatives, Zen mentors physician entrepreneurs, early-stage startups and health corporations adapting to global digital healthcare transformation, changing healthcare incentives, growth in emerging markets, and new disruptive technologies that re-engineer medicine.As Managing Director of Accelerated Medical Ventures, Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV’s portfolio spans Boston, Silicon Valley and China, including PillPack.com, Figure1.com, 3D-Matrix Medical [JASDAQ: 7777], Curoverse Genomics, PathFinder Regenerative Medicine [OTCQB: PFND], BitGym.com, Aptible, DirectDermatology.com and a couple of companies still in stealth mode.Alongside four world-renowned MIT biomaterials professors, Zen co-founded 3D-Matrix Medical Inc., serving as the first CEO for the venture-backed MIT regenerative medicine company whose injectable gel drug delivery products are treating patients and enabling new regenerative medicine research, with a successful IPO in 2011. He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures and Hewlett-Packard.Zen earned a Masters of Public & Private Management from Yale University and a BS in biomedical/electrical engineering from SMU.  He's married to another entrepreneur-turned-venture investor and they are raising three aspiring makers in Brookline, MA.

## Ray Muzyka
- Type: Angel
- Location: Edmonton, Alberta, Canada
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Health Care, Software, Information Technology

Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001.

## Joshua Landy
- Type: Angel
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Medical, Software, Wellness

Joshua Landy - Founder & Chief Medical Officer @ Figure 1

## Bryan W. Kerdman
- Type: Angel
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Debt Financing
- Focus: Mobile, mHealth, SaaS

Mr. Bryan W. Kerdman is Partner of Venture Fund at EdgeStone Capital Partners Inc., EdgeStone Capital Venture Fund I, L.P. and Bryker Fund I, L.P. Mr. Kerdman has served as Partner of Venture Fund at EdgeStone Capital Venture Fund II, L.P. He was a Partner of Bryker Technology Partners. He has twenty-five years experience creating, building andrunning high technology companies that specialize in mission-critical, high-volume transaction applications as well as enterprise software solutions. Mr. Kerdman is the founder of Bryker Data Systems Ltd and served as its President and Chief Executive Officer. He served as Chief Executive Officer of a number of other technology companies including Technolabs Canada and E-route. He served as Chairman of Datawire Communication Networks Inc. He serves as a Director of Datawire Communication Networks Inc., and SC Txlink LLC. He served as a Director of Varicent Software Inc. He served as a Director of Workbrain Corporation since December 2000, Solace Systems, Inc., and CiRBA Inc. since February 1, 2006. He served as a Director of Protus IP Solutions, Inc., INEA, Workbrain, Shoplogix, Inc., RSS Solutions, SlipStream Data, Pvelocity Inc. and Time Industrial.

## Jason Warner
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Information Technology, Developer Tools

Jason Warner is the MD at Redpoint. Jason cares deeply about the future of technology, developer experience, and growing companies. He is a people-oriented product technologist, who is passionate about building both the technical and human systems needed for scale and growth. Prior to joining GitHub, Jason was Vice President of Engineering atHeroku, the world’s leading PaaS and one of the largest cloud computing providers in the world. Before Heroku, Jason worked to make Linux accessible to everyone by leading product engineering for Ubuntu Desktop and Ubuntu Phone at Canonical. Jason is also an active speaker, writer, and advisor on cloud computing, technology and leadership. His activities include formally and informally advising startup and established executives, as well as active coaching and mentoring future product and technology leaders.Jason graduated from Pennsylvania State University with a BS in Computer Science, and Rensselaer University with an MS in Computer Science. He lives with his family in Victoria, British Columbia, where he writes, sketches and enjoys the water as much as possible.

## Edwin Liang
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Software, Health Care

Edwin Liang - CTO @ uknowa

## Edward Lando
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, Health Care

Edward Lando is the Managing Partner at Pareto Holdings.

## Carlo Perez
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Software, Health Care

Carlo Perez - CEO @ uknowa

## Julien Martel
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Software, Health Care

Julien Martel is a co-founder of DXA.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co